BRD4770, with the CAS number 1374601-40-7, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential as a therapeutic agent. It is characterized by its specific molecular structure, which includes various functional groups that contribute to its biological activity. The compound is often studied for its role in inhibiting certain enzymes or pathways relevant to disease processes, making it a candidate for drug development. In terms of physical properties, BRD4770 may exhibit solubility in organic solvents and has a defined melting point and boiling point, which are typical characteristics of small organic molecules. Its safety profile, including toxicity and environmental impact, is also assessed during research and development. Overall, BRD4770 represents a significant interest in pharmaceutical research, particularly in the context of targeted therapies and the development of new treatments for various conditions.

BRD4770

1374601-40-7: BRD4770, with the CAS number 1374601-40-7, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential as a therapeutic agent. It is characterized by its specific molecular structure, which includes various functional groups that contribute to its biological activity. The compound is often studied for its role in inhibiting certain enzymes or pathways relevant to disease processes, making it a candidate for drug development. In terms of physical properties, BRD4770 may exhibit solubility in organic solvents and has a defined melting point and boiling point, which are typical characteristics of small organic molecules. Its safety profile, including toxicity and environmental impact, is also assessed during research and development. Overall, BRD4770 represents a significant interest in pharmaceutical research, particularly in the context of targeted therapies and the development of new treatments for various conditions.

Methyl 2-Benzamido-1-(3-Phenylpropyl)-1H-Benzo[D]Imidazole-5-Carboxylate

<p>BRD4770 is a histone methyltransferase G9a inhibitor and induces cell senescence.</p>

CAS 1374601-40-7

BRD4770

BRD4770

Ref: IN-DA009BPB

Methyl 2-Benzamido-1-(3-Phenylpropyl)-1H-Benzo[D]Imidazole-5-Carboxylate

Ref: 54-OR1023970

BRD4770

Ref: 54-BUP05666

BRD4770

Ref: TM-T1923